Table 2 Univariate analyses of risk factors for BPF
Risk factor | BPF (%) (n = 16) | No BPF (%) (n = 171) | p-value |
|---|---|---|---|
Age, years (mean ± SD) | 61.38 ± 7.78 | 61.21 ± 7.43 | 0.935 |
Gender | 0.338 | ||
Male | 16 (100.0) | 154 (90.1) | |
Female | 0 (0) | 17 (9.9) | |
Albumin (mean ± SD) | 4.14 ± 0.41 | 4.14 ± 0.55 | 0.997 |
Comorbidity | 0.398 | ||
Yes | 3 (18.8) | 55 (32.2) | |
No | 13 (81.3) | 116 (67.8) | |
Operation side | 0.033 | ||
Right | 8 (50.0) | 40 (23.4) | |
Left | 8 (50.0) | 131 (76.6) | |
Neoadjuvant therapy [n (%)] | 0.765 | ||
Yes | 3 (18.8) | 41 (24.4) | |
No | 13 (81.3) | 127 (75.6) | |
Adjuvant chemotherapy [n (%)] | 0.428 | ||
Yes | 9 (56.3) | 105 (61.8) | |
No | 7 (43.8) | 65 (38.2) | |
Stage | 0.201 | ||
I | 5 (31.3) | 29 (16.9) | |
II | 3 (18.8) | 65 (37.8) | |
III | 8 (50.0) | 78 (45.3) | |
Surgical approach | 0.151 | ||
VATS | 0 (0.0) | 20 (11.7) | |
Thoracotomy | 16 (100.0) | 151 (88.3) | |
Re-operation | 0.043 | ||
Yes | 3 (18.8) | 7 (4.1) | |
No | 13 (81.3) | 164 (95.9) | |
TPFF | 0.044 | ||
Yes | 1 (6.3) | 52 (30.4) | |
No | 15 (93.8) | 119 (69.6) |